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Abstract
Guillain Barre Syndrome (GBS) is readily diagnosed when the presentation is that of ascending
weakness and areflexia. Atypical presentations with preserved, and at times, brisk reflexes, can be
a diagnostic dilemma. We describe a patient with GBS who presented with facial diplegia and
hyperreflexia on examination and discuss management options.
Background
Guillain-Barre syndrome (GBS) is usually easily identified
with its typical presentation of ascending weakness and
areflexia on examination. It may however present atypi-
cally with preserved, and at times, brisk reflexes, leading
to diagnostic dilemma. A patient with isolated facial
diplegia and hyperreflexia on examination is presented.
During the entire hospitalization, the patient developed
no motor weakness and remained ambulatory. Whether
treatment is warranted for this and other milder variants
of GBS is also discussed.
Case presentation
A-29-year-old right-handed Caucasian woman, who
works as a model, presented to the hospital with facial
weakness. She reported that a week previously she had a
sore throat and was seen by her doctor who prescribed
antibiotics. Four days later she developed paraesthesias in
her hands and feet along with severe myalgia (day 1 of
neurological manifestation). On day 3, she noted weak-
ness in eye closure when applying eyeliner. On Day 4, she
was at an audition, and was unable to smile for the cam-
era. Later that night, she participated in a runway show.
She was able to walk in high heels without difficulty.
However, concerns about her face brought her to the
emergency department after the show.
At presentation, neurological examination revealed facial
diplegia. She was unable to close both eyes, purse her lips
or smile. Deep tendon reflexes were 3(+) throughout with
flexor plantar responses. She had no weakness or sensory
loss in her limbs, and there were no respiratory or auto-
nomic features on examination. Cerebrospinal fluid
(CSF) showed two lymphocytes with a protein level of
162 mg/dL and normal glucose. Nerve conduction study
done on Day 6 showed partial denervation of facial nerves
with compound muscle actions potentials markedly
decreased bilaterally. No response could be obtained on
blink reflex studies bilaterally. There was no evidence of
demyelination in the limbs; F waves were present with no
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delay in latency [Table 1, 2]. Lyme serology was negative,
serum and CSF angiotensin converting enzyme levels
were 10 U/L (normal, 8–52 U/L). Tests for CSF VDRL and
HIV were non-reactive. Antiganglioside antibodies were
not sent and no imaging studies of the brain were carried
out as her presentation was consistent with a demyelinat-
ing peripheral neuropathy. The physician on hospital
service elected to treat her with IV immunoglobulin (IVIG
400 mg/kg/day) for five days. By the time above treatment
was initiated (Day 7) her paraesthesias had already
resolved. During her entire hospitalization, she developed
no motor weakness and remained ambulatory. At the
time of her discharge on Day 12 she showed some
improvement in her facial weakness and was able to
approximate her lips as well as furrow her eyebrows. Fol-
low up nerve conduction studies were not carried out.
When last seen 6 weeks after her first presentation, she
was able to smile normally and no facial weakness was
evident on examination. Her deep tendon reflexes were
1(+) bilaterally.
Discussion
Facial diplegia has a number of causes including Bell's
palsy, sarcoidosis (Uveo-parotid fever or Heerfordt Syn-
drome), Lyme disease, Hansen's disease (leprosy), diabe-
tes, brainstem encephalitis, brainstem stroke, herpes
zoster (Ramsay Hunt and Mekelson Rosenthal Syn-
drome), HIV and GBS. Isolated facial diplegia with mini-
mal to no motor limb weakness has been described as a
GBS variant [1,2]. Usually in these cases areflexia helps in
distinguishing GBS as the underlying etiology. Hyper-
reflexia as a variant in GBS has also been described and is
currently not thought to be inconsistent with the diagno-
sis. It is thought to be due to increased motor neuron
excitability and spinal inhibitory interneuron dysfunction
as evidenced by increased soleus H/M ratios and abnor-
mal appearance of H reflexes in the small muscles of the
hands and feet in some patients [3,4,6]. Hyperreflexia in
GBS patients has been associated with a milder degree of
peak disability, as is seen in this patient [6].
Our patient presented with isolated facial diplegia. The
fact that she was able to catwalk down a runaway in high
heels clearly argued against any lower limb weakness at
presentation. It is unclear however if GBS patients with
isolated facial diplegia warrant treatment or not. The
unpredictability of the early clinical course of GBS makes
it difficult to judge which patient shall worsen as the dis-
ease runs its course. Treating all these "mild" cases may
risk exposing patients to the potential side effects of IVIG
and plasmapheresis. There is also anecdotal evidence that
transient improvement in power or paraesthesias fol-
lowed by worsening may occur in relation to immune
treatment i.e. immune treatment itself may predispose a
patient to relapse [4,5]. In our case the treating physician
who first saw her at presentation to the hospital elected to
use IVIG. By the time treatment was initiated and we were
involved in her care the neurological syndrome had
already started to resolve as evidenced by the disappear-
ance of paraesthesias, hence it can be debated if the
Table 2: F waves
Nerve Minimum Latency
Med nerve® 28.5 ms
Tibial nerve® 54.3 ms
Table 1: Motor and Sensory Nerve Conductions
Nerve/Site Latency Amplitude Velocity
Median nerve (APB) Right
Med Wrist 3.6 ms 11.58 mV
Med Elbow 8.2 ms 9.857 mV 52 m/s
Tibial nerve (AH) Right
Med Mall 7.0 ms 9.479 mV
Pop fossa 17.0 ms 6.315 mV 41 m/s
Facial nerve®
Orb. Oculi® no response
Nasalis® 2.7 ms 0.194 mV
Facial nerve (L)
Orb oculi (L) no response
Nasalis (L) 2.4 ms 0.465 mV
Median sensory 3.5 ms 56 m/s
Ulnar sensory 3.2 ms 54 m/s
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patient's clinical outcome would have been any different
had treatment been withheld. In their article Green et.al
mention that treatment may be unnecessary in patients
who remain ambulatory during the second week of illness
[5]. Observation until the eight day though is advisable to
be certain that the disease does not progress or relapse.
Conclusion
It is not our intention by highlighting this case to discuss
the physiology behind brisk reflexes in GBS but rather to
raise the argument for withholding immunotherapy in
isolated facial diplegia variant of GBS until the eighth day
or so before committing these "mild" GBS patients, who
are still able to walk, to IVIG or plasmapheresis.
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